Health
A wonderful serenity has taken possession of my entire soul, like these sweet mornings of spring which I enjoy with my whole heart.
Report highlights private equity’s lesser-known strategy: nonprofit joint ventures – MedCity News
It is well known that private equity has significantly increased its presence in the healthcare sector, acquiring hospitals, doctor's offices...
Read moreDetails
This ear-based device could save patients from complications of brain hemorrhage – MedCity News
This week, the FDA granted revolutionary device designation for MarriageThe V-Link System, a non-invasive nerve stimulation device designed to treat...
Read moreDetails
FDA Approves First Neurostimulation Device for PTSD – MedCity News
This week, Neurovalenes“Modius Spero became the first neuromodulation device to gain FDA approval to treat PTSD. Veterans, who face disproportionately...
Read moreDetails
Anthropic launches Claude Science with Court Pharma ahead of IPO – MedCity News
Anthropic deploys Claude Science, an AI workshop for pharmaceutical researchers. The bustling AI startup says this new product goes beyond...
Read moreDetails
Healthcare Moves: A Monthly Summary of Hires, Departures and Layoffs – MedCity News
This overview is published monthly. It aims to highlight some of the latest hiring news in the healthcare industry and...
Read moreDetails
FDA approves thyroid eye disease drug from Viridian, rival to blockbuster Amgen Med – MedCity News
A Viridian Therapeutics drug for thyroid eye disease now has FDA approvalmaking it just the second treatment for this inflammatory...
Read moreDetails
EMA: the benefits of the inflammation drug Amgen and Vifor no longer outweigh the risks – MedCity News
Regulatory pressure mounts on Amgen's inflammatory disorder drug Tavneos at the European Medicines Agency (EMA) recommend revocation of product approval...
Read moreDetails
Why ‘always open’ is the wrong way to measure the hospital crisis – MedCity News
One of the most common ways to measure the nation's hospital crisis is to count closures, but one hospital financing...
Read moreDetails
New FDA deal keeps Gilead drug competitive with AstraZeneca and Daiichi in breast cancer treatment – MedCity News
The FDA has expanded approval of a targeted therapy from Gilead Sciences as a new first-line treatment for triple-negative breast...
Read moreDetails
Things to Consider Before Taking Your Biotech Company Public – MedCity News
After a few gloomy years, biotech IPOs rebound in 2026. A new record for the sector most cash raised by...
Read moreDetails
Trusted news coverage delivering accurate reporting, breaking headlines, and insightful analysis on global events, business, politics, and tech.